ERYtech Pharma Receives FDA IND Clearance to Initiate a Clinical Study in Acute Lymphoblastic Leukemia in the U.S.
4/3/2013 10:57:29 AM
More...
|
ERYtech Pharma Signs Licensing and Distribution Agreement With Orphan Europe for GRASPA® in Europe
11/26/2012 11:29:57 AM
More...
|
ERYtech Pharma Announces the Oral Presentation of Positive Phase II Clinical Trial Results in Acute Lymphoblastic Leukemia
6/18/2012 10:34:57 AM
More...
|
ERYtech Pharma's Sickle Cell Treatment Receives Positive Opinion for Orphan Drug Designation from the European Medicines Agency
6/13/2012 10:24:22 AM
More...
|
ERYtech Pharma Receives € 7 Million from OSEO to Lead the TEDAC Personalized Medicine Project in Cancer
6/5/2012 10:50:43 AM
More...
|
ERYtech Pharma Completes the Enrollment of Patients in Its Phase I Clinical Trial in Pancreatic Cancer
6/27/2011 9:56:44 AM
More...
|
ERYtech Pharma to Partner with Teva Pharmaceutical Industries Limited (TEVA) for Long Term Distribution Agreement in Israel
5/17/2011 10:03:50 AM
More...
|
ERYtech Pharma To Present Promising Results for the Treatment of Sickle Cell Disease
3/14/2011 8:47:57 AM
More...
|
ERYtech Pharma Announces Completion of Enrollment of a Phase II Clinical Trial for GRASPA(R) in First-Line for Elderly Patients with Acute Lymphoblastic Leukaemia
3/9/2011 9:15:11 AM
More...
|
ERYtech Pharma Announces Appointment of Marc Beer to the Supervisory Board
2/17/2011 8:27:18 AM
More...
|
|